Clinical Trial Update: Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether corticosteroids can reduce seizure frequency in neurocysticercosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocysticercosis

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Neurocysticercosis | Phase 3 | Status: COMPLETED